Effect of modification of plasma membrane fatty acid composition on fluidity and methotrexate transport in L1210 murine leukemia cells.
D000818:Animals; D001693:Biological Transport, Active; D002462:Cell Membrane / Q000378:metabolism; D004041:Dietary Fats / Q000008:administration & dosage; D004578:Electron Spin Resonance Spectroscopy; D005227:Fatty Acids / Q000378:metabolism*; D007700:Kinetics; D007939:Leukemia L1210 / Q000378:metabolism*; D008297:Male; D008560:Membrane Fluidity; D008563:Membrane Lipids / Q000378:metabolism*; D008727:Methotrexate / Q000378:metabolism*; D051379:Mice; D008811:Mice, Inbred DBA
D004041:Dietary Fats; D005227:Fatty Acids; D008563:Membrane Lipids; D008727:Methotrexate